Should I Buy IBEX? IBEX 2026 Analysis

Should You Buy Ibex Ltd (IBEX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

34.980

1 Day change

2.25%

52 Week Range

42.990

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer: price action/indicators are bearish and the near-term pattern model points to further downside.
Major event risk is immediate (earnings after-hours today); with no proprietary buy signals, the risk/reward is not favorable for a jump-in-now entry.
Consider only after (1) earnings clarity and (2) the stock reclaims key levels (back above the pivot ~36.94) or shows a momentum reversal off support.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Technical Analysis

Trend/Momentum: Bearish short-term momentum—MACD histogram is negative (-0.396) and expanding lower.
RSI: RSI(6) at ~26 suggests the stock is stretched/oversold, but oversold alone is not a buy trigger without confirmation.
Moving averages: Converging MAs indicates a transition/indecision phase, but momentum currently favors sellers.
Key levels: Price ~34.51 is just above S1 support (34.06). A clean break below ~34.06 increases risk toward S2 ~32.28. Upside resistance/pivot sits much higher at ~36.94.
Pattern-based forward odds (similar candlesticks): 60% chance of -1.35% next day, -3.44% next week, -0.9% next month → near-term bias remains downward.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment (OI): Put/Call open interest ratio 0.38 (call-heavy) leans bullish positioning, but OI is small (calls 190 vs puts 72).
Activity: Extremely low options volume today (total volume 1; puts 0), so “sentiment” from volume is not reliable.
Volatility: IV 30d ~85.37 vs historical vol ~39.89 and IV percentile ~85 → options are pricing a large move (consistent with imminent earnings), increasing event-driven uncertainty for a buy-today decision.
Liquidity note: With such low volume/open interest, spreads/slippage can be meaningful, limiting interpretability.

Technical Summary

Sell

Buy

Positive Catalysts

- Company expanding AI-driven customer experience solutions (potential growth narrative catalyst).
- Track record: Over the past two years, IBEX reportedly beat EPS and revenue estimates ~88% of the time.
- Estimates trend: EPS saw one upward revision (and one downward) in last 3 months; revenue estimates saw one upward and no downward revisions.
- Raised 2026 revenue outlook to ~$620M (if reaffirmed/raised again on earnings, could support upside).

Neutral/Negative Catalysts

- Earnings catalyst is immediate (after market close today): buying now is essentially taking an earnings coin-flip with elevated implied volatility.
- News headline risk: Mention of a “significant year-over-year revenue decline of 99.9% to $157M” for the upcoming print can spook the tape even if there are one-offs/accounting effects.
- Technical backdrop is weak (bearish MACD, price sitting near support), increasing odds that a disappointing/unclear report breaks support.
- Broader tape: S&P 500 down (-0.48%) in the latest session—minor headwind to risk appetite.

Financial Performance

Latest reported quarter: 2026/Q1.
Growth: Revenue $151.179M (+16.55% YoY), Net Income $12.042M (+59.90% YoY), EPS $0.82 (+90.70% YoY) → strong earnings growth trend.
Profitability: Gross margin 26.61% (down ~2.24% YoY) → growth is solid, but margins are slipping and bear watching.
Setup into earnings: Fundamental trend was positive in the last reported quarter, but the next report is the key near-term driver and is being priced with very high IV.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No formal analyst rating/price-target history was provided in the dataset.
What we do have (estimates trend): In the last 3 months, EPS estimates had one upward and one downward revision (mixed), while revenue estimates had one upward revision and no downward changes (mildly positive).
Wall Street-style pros: improving EPS/net income trend in the last quarter; raised 2026 revenue outlook; AI product expansion narrative.
Wall Street-style cons: margin compression; confusing/negative-sounding near-term revenue commentary; high uncertainty into earnings (reflected by very elevated implied volatility).
Influential/political flows: No recent congress trading data available; hedge funds and insiders flagged as neutral (no notable recent accumulation/distribution).

2 Analyst Rating

Wall Street analysts forecast IBEX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IBEX is 41 USD with a low forecast of 40 USD and a high forecast of 42 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

2 Hold

0 Sell

Hold

Current: 34.210

Low

Averages

High

Current: 34.210

Low

Averages

High

Baird

David Koning

Outperform -> Neutral

downgrade

$30

AI Analysis

2025-05-12

Reason